What I found interesting was this:
Quote:
|
In addition, those other patients with Luminal-HER2 subtype could benefit from a second treatment with trastuzumab in order to decrease the second peak of recurrences.
|
I recall discussion here from way back, that perhaps triple positives could do with a "booster" of Herceptin at the 5 or 7 year mark.
Hopeful